Key result
Elevated NT-proBNP is universally present in hemodialysis patients and tracks with left ventricular dysfunction.
Why the study?
Patients with ESRD on dialysis have high cardiovascular morbidity and mortality, and traditional risk factor modifications, medications, and revascularization show limited effectiveness. Consequently, optimal strategies for diagnosing and managing cardiovascular disease in ESRD need refinement, motivating evaluation of correlations among clinical cardiac manifestations, 2D echocardiography, and serum NT-proBNP.
Observational (n=61)
No
In ESRD patients on maintenance hemodialysis, standard NT-proBNP cutoffs are unreliable for diagnosing heart failure due to universally elevated baseline levels, though markedly elevated levels (>11,500 pg/ml) correlate with echocardiographic dysfunction and predict heart failure hospitalization and mortality.
Answers are grounded in this paper and cite their sources.
NT-proBNP may aid cardiac assessment in hemodialysis patients; extends prior correlations but leaves open clinical utility pending prospective data.
Background: The incidence of cardiovascular morbidity and mortality in people with end stage renal disease (ESRD) on dialysis is higher than in the general population. The US Renal Data System estimates the prevalence of cardiovascular disease in ESRD patients on hemodialysis (HD) a 70.6% and that in peritoneal dialysis patients 57.8%. Furthermore, arrhythmia / cardiac arrest is the only cause of death in 40% of dialysis patients. There is little evidence to support the effectiveness of traditional risk factor modification approaches, drug use or lifestyle changes in this population. Furthermore, coronary artery revascularization in patients with documented coronary artery disease did not alter arrhythmia mortality rates. Therefore, optimal strategies for the diagnosis, prevention and management of cardiovascular disease need to be modified in patients with ESRD. Method: Sixty one patients with end stage renal disease on maintenance hemodialysis attending OPD / IPD or dialysis centre were studied using random sampling method. We conveniently took 61 patients who are adequately dialysed (KT/V urea > 1.2 for last 4 weeks) out of total 165 patients. Their demographic profile, clinical (cardiac symptoms) and biochemical profile (NT-proBNP) was recorded. Assessment with 2D echocardiography was done to find cardiac structural or functional abnormality. Results: All patients had significantly raised NT-proBNP level with mean NT-proBNP level of 15912.1 ± 13078.3 pg/ml. Prevalence of LV systolic dysfunction was 13.11%; out of them 3.28%, 4.9% and 4.9% patients had mild, moderate and severe systolic dysfunction respectively. Prevalence of LV hypertrophy (100%) and Diastolic dysfunction (98.36%) was very high. Significant correlation found between NT proBNP level and echocardiographic parameters. No significant correlation found between interdialytic weight gain (IDWG) and DD (P = 0.174), IDWG and dyspnea NYHA grade (P = 0.929) or IDWG and NT-proBNP level (P value = 0.39). Over 1 year of study period, 7 patients were hospitalized due to heart failure and 2 patients were died due to other causes with mean NT-proBNP level 25472.85 pg/ml and 30506 pg/ml respectively. Conclusions: NT-proBNP is not a reliable marker for heart failure in end stage renal disease patients. However, if we increase it cut off to more than 11500 pg/ml that is 20 times more than present value, it may have diagnostic value. It can also have prognostic significance as high value is associated with increased risk of heart failure and mortality.
No takes yet. Share an insight, caveat, or question.
Godhaviya et al. (2026) conducted an observational in End-stage renal disease on maintenance hemodialysis (n=61). Serum NT-proBNP levels and 2D echocardiographic evaluation was evaluated on Association between serum NT-proBNP levels and left ventricular diastolic dysfunction on 2D echocardiography (p=0.0006). Serum NT-proBNP levels were elevated in 100% of hemodialysis patients and correlated with LV diastolic and systolic dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: